The Australian Centre for Blood Diseases (ACBD) have launched their Community Engagement Program. This program aims to connect dedicated researchers at the ACBD with community members (often called consumers) who have experienced a blood disorder or cancer. Consumers will be partnered with researchers or a research group, bringing their valuable lived experiences to the team and contributing to our shared goal of turning new discoveries into better patient outcomes.
Researchers at Monash Health are involved in a wide variety of research studies to better understand COVID-19 and provide better treatment to the community.
Monash Heart is currently recruiting for a clinical trial known as the Lp(a) HORIZON study for patients who have a history of Cardiovascular disease and high Lipoprotein (a) [Lp(a)] levels. The purpose of the study is to determine if a new investigational therapy helps lower the risk of having a serious cardiovascular event.
Lp(a) is a substance made up of fat and protein that carries cholesterol in your blood. Elevated Lp(a) is a hereditary condition that cannot be reduced through diet, exercise or current drug therapies. High levels of Lp(a) put you at risk of Cardiovascular disease (heart attacks, stroke, blood clots in the legs).
You are invited to participate in the study if you have a history of cardiovascular disease. If you do not know your Lp(a) levels, this can be tested at our Screening visit .
The Monash Health Department of Oncology provides more than 1.5 million residents of southern Melbourne with access to world leading cancer treatment over four locations within the Monash Health service.
For a list of current Oncology trials, contact numbers and further information, please visit the Oncology page.
Monash Children’s Clinical Trials Centre is taking part in a clinical research study called the Boost Study. This study is looking at a potential new vaccine that aims to protect against 5 different types of meningococcal infections (A,B,C,W and Y). The study will look at safety and also whether this vaccine may act as a booster in people who have already received a licensed vaccine against meningococcal types ACWY.
Researchers are encouraged to partner with consumers in all stages of research.
Information, guidance, training and access to consumer and community partners may be located through these excellent resources:
During 2021, Monash Partners will be facilitating lunch time seminars for researchers on consumer and community involvement in research. Monash Health will be participating in these seminars.